We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abrishamy’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A85245 · Current
Licensed to practise in California · since 2003 · expires 2027-04-30 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$25,702
Medicare paid this office $25,702 for 90 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Largest Original Medicare bills
Short return visit (20+ min)
70
$9,609
$66
Destruction of precancer skin growth, 1 growth
54
$4,426
$47
Destruction of skin growth, 1-14 growths
21
$2,240
$83
Biopsy of related skin growth, first growth
25
$2,074
$77
Return visit (30+ min)
15
$2,030
$107
See all 8 services
Every Original Medicare service billed
Short return visit (20+ min)
70
$9,609
$66
Destruction of precancer skin growth, 1 growth
54
$4,426
$47
Destruction of skin growth, 1-14 growths
21
$2,240
$83
Biopsy of related skin growth, first growth
25
$2,074
$77
Return visit (30+ min)
15
$2,030
$107
Destruction of precancer skin growth, 2-14 growths
42
$1,882
$6
New patient visit (30+ min)
13
$1,081
$83
Short return visit
15
$740
$41
Procedures Medicare counted
Procedure volume Medicare published
Removal of skin lesions
238
More than 81% of doctors who do this
Skin biopsy
48
More than 69% of doctors who do this
Procedures year by year
Procedures billed to Original Medicare by year
Procedure
2019
2020
2021
2022
2023
2024
Destruction of precancer skin growth, 2-14 growths
409
298
303
328
245
333
Destruction of precancer skin growth, 1 growth
106
59
76
72
85
95
Biopsy of related skin growth, first growth
64
35
24
29
33
27
Destruction of skin growth, 1-14 growths
19
19
22
20
26
27
Biopsy of related skin growth, each additional growth
21
16
–
–
–
–
Destruction of precancer skin growth, 15 or more growths
–
13
–
–
–
–
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
90 Original Medicare patients in 2024. Average age 73 · Women 47% · Health risk score 0.75. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 59% · Diabetes 21% · Chronic kidney disease 17% · Coronary heart disease 16% · Cancer 14%.
The office billed $76,671, Medicare allowed $37,046 and paid $25,702; for 707 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
Original Medicare by year
2024
90
707
73
0.75
$76,671
$25,702
2023
112
623
72
0.98
$78,248
$26,897
2022
109
659
73
0.87
$68,715
$23,231
2021
107
656
73
0.88
$72,514
$25,584
2020
128
670
73
0.91
$75,786
$25,968
2019
159
902
73
1.23
$94,437
$32,136
2018
141
944
73
1.15
$57,744
$31,108
2017
150
984
73
0.94
$64,336
$34,997
2016
182
1,179
73
1.09
$84,012
$39,470
2015
146
1,067
74
1.10
$53,954
$34,177
2014
170
1,084
72
0.98
$62,680
$40,742
2013
182
1,138
72
0.98
$73,284
$46,142
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
Original Medicare services billed in 2023
Short return visit (20+ min)
82
$8,271
$63
Destruction of precancer skin growth, 1 growth
58
$3,968
$47
Biopsy of related skin growth, first growth
31
$2,576
$78
Destruction of skin growth, 1-14 growths
19
$2,511
$97
Return visit (30+ min)
19
$2,370
$95
New patient visit (30+ min)
22
$1,839
$84
Destruction of precancer skin growth, 2-14 growths
45
$1,398
$6
Short return visit
13
$595
$42
2022: 7 services
Original Medicare services billed in 2022
Short return visit (20+ min)
78
$8,554
$68
Destruction of precancer skin growth, 1 growth
48
$3,386
$47
Biopsy of related skin growth, first growth
28
$2,472
$85
Destruction of skin growth, 1-14 growths
13
$1,938
$97
Destruction of precancer skin growth, 2-14 growths
45
$1,864
$6
New patient visit (30+ min)
24
$1,650
$69
Short return visit
18
$900
$45
2021: 7 services
Original Medicare services billed in 2021
Short return visit (20+ min)
85
$9,302
$66
Destruction of precancer skin growth, 1 growth
55
$3,482
$46
Destruction of skin growth, 1-14 growths
18
$2,170
$99
Biopsy of related skin growth, first growth
23
$2,089
$87
Destruction of precancer skin growth, 2-14 growths
44
$1,705
$6
New patient visit (30+ min)
12
$1,194
$100
Short return visit
23
$1,026
$43
2020: 10 services
Original Medicare services billed in 2020
Short return visit (20+ min)
79
$6,787
$58
Return visit (30+ min)
40
$3,763
$82
Destruction of precancer skin growth, 1 growth
44
$2,649
$45
Biopsy of related skin growth, first growth
34
$2,635
$75
Destruction of precancer skin growth, 15 or more growths
12
$1,825
$140
Destruction of skin growth, 1-14 growths
13
$1,646
$87
Destruction of precancer skin growth, 2-14 growths
36
$1,574
$5
Biopsy of related skin growth, each additional growth
12
$781
$49
New patient visit (30+ min)
12
$701
$58
New patient visit (15+ min)
11
$428
$39
2019: 9 services
Original Medicare services billed in 2019
Short return visit (20+ min)
105
$8,751
$53
Biopsy of related skin growth, first growth
60
$5,230
$82
Destruction of precancer skin growth, 1 growth
75
$4,774
$45
Return visit (30+ min)
40
$4,413
$88
Destruction of precancer skin growth, 2-14 growths
62
$1,998
$5
Destruction of skin growth, 1-14 growths
13
$1,592
$84
New patient visit (30+ min)
13
$1,218
$94
Biopsy of related skin growth, each additional growth
17
$1,013
$48
New patient visit (15+ min)
16
$604
$38
2018: 6 services
Original Medicare services billed in 2018
Short return visit (20+ min)
90
$8,290
$56
Return visit (30+ min)
52
$4,763
$70
Destruction of precancer skin growth, 1 growth
64
$4,612
$48
Biopsy of single growth of skin and/or tissue
42
$3,790
$81
Destruction of precancer skin growth, 2-14 growths
56
$2,115
$5
Biopsy of each additional growth of skin and/or tissue
15
$734
$28
2017: 9 services
Original Medicare services billed in 2017
Short return visit (20+ min)
85
$7,369
$54
Return visit (30+ min)
66
$6,837
$80
Destruction of precancer skin growth, 1 growth
77
$5,119
$46
Biopsy of single growth of skin and/or tissue
49
$4,323
$79
Destruction of precancer skin growth, 2-14 growths
64
$2,263
$5
Biopsy of each additional growth of skin and/or tissue
14
$621
$28
New patient visit (30+ min)
11
$576
$52
New patient visit (15+ min)
11
$522
$47
Short return visit
12
$458
$35
2016: 8 services
Original Medicare services billed in 2016
Short return visit (20+ min)
116
$9,176
$53
Biopsy of single growth of skin and/or tissue
71
$6,643
$79
Destruction of precancer skin growth, 1 growth
87
$6,207
$48
Return visit (30+ min)
59
$5,414
$74
Destruction of precancer skin growth, 2-14 growths
67
$2,692
$5
Biopsy of each additional growth of skin and/or tissue
31
$1,204
$28
New patient visit (30+ min)
19
$1,135
$60
Short return visit
20
$707
$34
2015: 9 services
Original Medicare services billed in 2015
Short return visit (20+ min)
100
$8,376
$53
Destruction of precancer skin growth, 1 growth
65
$5,435
$49
Biopsy of single growth of skin and/or tissue
60
$5,366
$83
Destruction of precancer skin growth, 2-14 growths
55
$2,719
$5
Destruction of precancer skin growth, 15 or more growths
13
$2,386
$126
New patient visit (15+ min)
29
$1,713
$59
Short return visit
37
$1,555
$37
Biopsy of each additional growth of skin and/or tissue
25
$1,011
$28
New patient visit (30+ min)
12
$908
$76
2014: 10 services
Original Medicare services billed in 2014
Short return visit (20+ min)
129
$10,888
$53
Biopsy of single growth of skin and/or tissue
80
$7,006
$81
Destruction of precancer skin growth, 1 growth
73
$6,077
$56
Destruction of precancer skin growth, 2-14 growths
63
$4,351
$9
Destruction of precancer skin growth, 15 or more growths
26
$3,991
$121
New patient visit (15+ min)
24
$1,343
$56
Biopsy of each additional growth of skin and/or tissue
31
$1,036
$27
New patient visit (30+ min)
12
$932
$78
Short return visit
22
$891
$34
Office for the evaluation and management of established patient that may not require presence of healthcare professional
11
$210
$18
2013: 11 services
Original Medicare services billed in 2013
Short return visit (20+ min)
115
$9,230
$52
Biopsy of single growth of skin and/or tissue
64
$6,521
$88
Destruction of precancer skin growth, 1 growth
72
$5,808
$60
Destruction of precancer skin growth, 15 or more growths
25
$5,000
$143
Destruction of precancer skin growth, 2-14 growths
57
$2,501
$6
New patient visit (30+ min)
26
$1,996
$77
Short return visit
37
$1,508
$37
New patient visit (15+ min)
28
$1,251
$45
Biopsy of each additional growth of skin and/or tissue
29
$998
$28
Injection into skin growth, 1-7 growths
13
$758
$42
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
12
$22
—None
Drugs they prescribed that Part D paid
$13,592
Pharmacies billed $13,592 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 168) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
146 generic and 22 brand-name prescriptions · $13,592 in drug cost · 21 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Clobetasol Propionate
12
$705
$59
Triamcinolone Acetonide
19
$192
$10
Methylprednisolone
11
$61
$6
Year by year
Part D prescribing by year
2024
168
53
0% (0)
13%
$13,592
2023
138
45
0% (0)
11%
$26,309
2022
159
52
0% (0)
16%
$23,187
2021
159
51
—None
17%
$6,180
2020
165
57
—None
13%
$9,290
2019
154
55
0% (0)
12%
$9,542
2018
103
42
0% (0)
17%
$8,326
2017
88
39
—None
13%
$4,993
2016
89
43
—None
17%
$7,674
2015
84
35
0% (0)
13%
$7,728
2014
85
46
—None
16%
$4,573
2013
110
44
—None
16%
$7,995
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
Part D drugs prescribed in 2023
Doxycycline Hyclate
17
$392
$23
Triamcinolone Acetonide
21
$162
$8
2022: 2 drugs
Part D drugs prescribed in 2022
Triamcinolone Acetonide
26
$331
$13
Doxycycline Hyclate
11
$109
$10
2021: 3 drugs
Part D drugs prescribed in 2021
Triamcinolone Acetonide
18
$159
$9
Losartan-Hydrochlorothiazide
19
$55
$3
Fluconazole
11
$35
$3
2020: 2 drugs
Part D drugs prescribed in 2020
Doxycycline Hyclate
17
$367
$22
Triamcinolone Acetonide
23
$180
$8
2019: 3 drugs
Part D drugs prescribed in 2019
Clobetasol Propionate
12
$1,588
$132
Triamcinolone Acetonide
40
$358
$9
Valacyclovir
11
$199
$18
2018: 2 drugs
Part D drugs prescribed in 2018
Ketoconazole
14
$658
$47
Triamcinolone Acetonide
22
$252
$11
2017: 1 drug
Part D drugs prescribed in 2017
Triamcinolone Acetonide
24
$244
$10
2016: 1 drug
Part D drugs prescribed in 2016
Clobetasol Propionate
12
$2,190
$182
2015: 3 drugs
Part D drugs prescribed in 2015
Clobetasol Propionate
26
$5,823
$224
Ketoconazole
11
$456
$41
Triamcinolone Acetonide
16
$138
$9
2014: 2 drugs
Part D drugs prescribed in 2014
Clobetasol Propionate
11
$1,552
$141
Triamcinolone Acetonide
21
$249
$12
2013: 3 drugs
Part D drugs prescribed in 2013
Clobetasol Propionate
13
$2,779
$214
Ketoconazole
20
$375
$19
Triamcinolone Acetonide
27
$349
$13
Money from drug and device companies
$931 in 2025
Industry payments by year
2025
11
19
—None
$931
2024
6
18
—None
$768
2023
7
26
—None
$1,541
2022
7
22
—None
$858
2021
8
24
—None
$640
2020
3
12
—None
$211
2019
6
29
—None
$759
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.